Children’s Hospital Colorado Announces Innovative In-House Whole-Genome Sequencing Lab
Setting the standard through dynamic genomic technology platform, improving patient outcomes AURORA, Colo., March 12, 2025 /PRNewswire/ -- The Children's...
DNA
Children’s Hospital Colorado Announces Innovative In-House Whole-Genome Sequencing Lab
Setting the standard through dynamic genomic technology platform, improving patient outcomes AURORA, Colo., March 12, 2025 /PRNewswire/ -- The Children's...
Next-Gen Cancer Treatment: Rakovina’s AI-Driven ATR Inhibitors Enter Preclinical Testing
Harnessing generative AI to develop targeted therapies for DNA damage response, including hard-to-treat central nervous system malignanciesVANCOUVER, British Columbia, March...
ZyVersa Therapeutics Highlights Data Demonstrating Inflammasome Inhibition Reduces Neuroinflammation and Pathological Brain Deposition of Amyloid Beta in Alzheimer’s Disease Mouse Model
Alzheimer’s disease (AD), affecting around 6.9 million people in the US, is ranked as the seventh leading cause of death...
Aprea Therapeutics Announces Agreement with MD Anderson Cancer Center to Explore APR-1051 as a Potential Treatment for Head and Neck Squamous Cell Carcinoma (HNSCC)
DOYLESTOWN, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company...
Glass House Brands to Host Fourth Quarter and Full Year 2024 Conference Call on March 25, 2025
LONG BEACH, Calif. and TORONTO, March 11, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company")...
Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma
Enhanced assay granted approval by New York State’s Clinical Lab Evaluation Program (CLEP) for patients with DLBCL clonoSEQ is the...
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2024 Financial Results
Additional Phase 2 data for vilastobart, a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with atezolizumab in patients with MSS CRC anticipated...
Illumina addresses recent developments in China
Announces Fiscal Year 2025 Non-GAAP Diluted EPS of Approximately $4.50 SAN DIEGO, March 10, 2025 /PRNewswire/ -- Illumina, Inc. (Nasdaq:...
Base Molecular Resonance™ Technologies Announces Breakthrough in DNA Signature Detection, Expanding the Boundaries of Quantum Physics Technology
Revolutionizing Law Enforcement, Medical and Military Applications STUART, Fla., March 10, 2025 /PRNewswire/ -- Base Molecular Resonance™ Technologies (BMRT), a...
Tethis and Sheba Medical Center announce research collaboration to advance AI-powered liquid biopsy in rectal cancer
MILAN and TEL HASHOMER, Israel, March 10, 2025 /PRNewswire/ -- Tethis S.p.A., a pioneer in standardized liquid biopsy platform development, and...
Curia Announces Strategic Refinancing to Support Continued Growth
ALBANY, N.Y., March 07, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization,...
RAPT Therapeutics to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., March 07, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company...
Full Circles Therapeutics Secures U.S. Patent Allowance for Targeted Genome Modification Using Circular Single-Stranded DNA
CAMBRIDGE, Mass., March 7, 2025 /PRNewswire/ -- Full Circles Therapeutics, a leader in next-generation genome engineering, announces that the United...
Duquesne Nanomedicine Lab Making Big Strides with Tiny Particles
PITTSBURGH, March 6, 2025 /PRNewswire/ -- Duquesne University's Nanomedicine Manufacturing Laboratory (NML) is taking tiny particles and using them to...
HyBryte™ Treatment Studies Presented at Two Medical Conferences in March
Two Presentations Highlight Data Demonstrating Hypericin Photodynamic Therapy Potential with a Preliminary Comparison to Current Therapy PRINCETON, N.J., March 6,...
St. Baldrick’s Foundation Awards $1.4 Million in Fellowships to Advance Childhood Cancer Research
Los Angeles, California--(Newsfile Corp. - March 6, 2025) - The St. Baldrick's Foundation, the largest charity funder of childhood cancer...
NIIMBL Announces RFA for Optimizing Long-read Next-generation Sequencing Capabilities
NEWARK, Del., March 4, 2025 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce...
IDENTIFYSENSORS RAISES $20 MILLION TO ADVANCE NEW DIGITAL DIAGNOSTICS PLATFORM
CLEVELAND, March 3, 2025 /PRNewswire/ -- IdentifySensors Biologics, a leading developer of digital diagnostic technologies, has raised $20 million to...
Akari Therapeutics Announces $7.6 Million Private Placement Offering Led by Existing Shareholders and Insiders Priced at the Market Under Nasdaq Rules
BOSTON and LONDON, March 03, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics Plc (Nasdaq: AKTX), a biotechnology company developing next-generation precision...